Casdin Capital’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4M | Sell |
1,775,000
-270,000
| -13% | -$7.67M | 4.59% | 6 |
|
|
2025
Q1 | $60.4M | Hold |
2,045,000
| – | – | 4.93% | 5 |
|
|
2024
Q4 | $59.5M | Sell |
2,045,000
-39,841
| -2% | -$1.16M | 3.96% | 7 |
|
|
2024
Q3 | $95.8M | Hold |
2,084,841
| – | – | 6.38% | 7 |
|
|
2024
Q2 | $85.2M | Hold |
2,084,841
| – | – | 6.5% | 6 |
|
|
2024
Q1 | $53.2M | Buy |
2,084,841
+909,091
| +77% | +$23.2M | 3.96% | 7 |
|
|
2023
Q4 | $10.6M | Sell |
1,175,750
-74,250
| -6% | -$672K | 1.04% | 21 |
|
|
2023
Q3 | $7.98M | Buy |
1,250,000
+400,000
| +47% | +$2.55M | 0.88% | 23 |
|
|
2023
Q2 | $9.43M | Hold |
850,000
| – | – | 0.82% | 26 |
|
|
2023
Q1 | $13M | Hold |
850,000
| – | – | 1.07% | 25 |
|
|
2022
Q4 | $18.9M | Buy |
+850,000
| New | +$18.9M | 1.46% | 19 |
|